26 reports

And there is no prophylactic drug that negates the need for pain relief. "

  • Pain Relief
  • United States
  • Allergan plc
  • Amgen Inc.
  • Pfizer Inc.

PAIN RELIEF REMEDIES GROWTH IN ALTERNATIVE THERAPIES CHAPTER ##: PAIN AILMENTS AND SUFFERERS RESPONDING TO PAIN AND SICKNESS: A NUANCED APPROACH Table ##-##: How Consumers Respond to Pain and Sickness: Adults Reporting Moderate-to- Severe Suffering, by Illness/ Condition, 2016 GATHERI

  • Chronic Pain
  • Healthcare
  • Pain Relief
  • United States
  • Demand

and Others ## Table ##: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others ## Table ##: Market Shares of Leading Oral

  • Opioid
  • Pain Relief
  • United States
  • Demand
  • Market Shares

Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others.............. ## Table ##: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Ot

  • Opioid
  • Pain Relief
  • United States
  • Demand
  • Market Shares

However, rizatriptan may provide better pain relief than many of the other triptans.

  • Pain Relief
  • United States
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • Analgesics and Other Pain Relievers
  • COMPANY: PRESTIGE BRANDS HOLDINGS, INC. ADDRESS: 660 WHITE PLAINS RD.

It may be combined with other drugs to provide even greater pain relief.

  • Pain Relief
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SENSUS RLS - USE OF WEARABLE PAIN RELIEF TECHNOLOGY IN RESTLESS LEG SYNDROME
  • MAY 08, 2017: NEUROMETRIX REPORTS SUBSTANTIAL EXPANSION OF INTERNATIONAL INTELLECTUAL PROPERTY ASSETS FOR QUELL WEARABLE PAIN RELIEF TECHNOLOGY
  • Pain Relief
  • United States
  • Company Financials
  • Product Initiative
  • NeuroMetrix, Inc.
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION
  • PAIN RELIEF DEVICE - PRODUCT STATUS
  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company
  • 4.3 Challenges

Slow Onset: While triptans have improved the treatment of migraine, their onset of pain relief is relatively slow.

  • OTC
  • Pain Relief
  • United States
  • World
  • Amgen Inc.

Worth to note is the rapidly installed and long lasting pain relief achieved by the MCS-Injection therapy.

  • Neurology
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • Nov 30, 2015: CapGenesis Files Five Orphan Drug Designation Requests with the FDA and EMA for CGS-200 as a Topical Analgesic
  • Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Drug Profiles

The authors conclude that the capsaicin ##% patch provided non-inferior pain relief compared with pregabalin, in addition to a shorter median time to pain relief, fewer systemic side effects and greater treatment satisfaction.

  • Hospital
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • Cluster Headache Syndrome - Companies Involved in Therapeutics Development
  • CLUSTER HEADACHE SYNDROME - PIPELINE BY ELI LILLY AND COMPANY, H2 2017

The company' s products include CNS drugs, analgesic drugs, drugs for cluster headaches treatment, drugs for moderate to severe pain relief and long-acting injections for CNS diseases.

  • OTC
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • KETOPROFEN - DRUG PROFILE
  • UBROGEPANT - DRUG PROFILE

A key secondary endpoint of this trial is pain relief at ## min, aimed at demonstrating the rapid relief profile of M##.

  • Antimigraine
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Product Development Milestones

Excessive use of acute pain-relief medication is common among people who suffer from migraine.

  • OTC
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Companies Involved in Therapeutics Development

Primary outcome measures include pain freedom, pain relief, number of participants with adverse events within ## hours post dose, number of participants with adverse events within ## days post dose and number of participants discontinued from study due to adverse events.

  • Pain Relief
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The primary efficacy endpoint of the trial is pain relief as reported on a visual analog scale (VAS) in a subject diary, assessed through ## hours from initial dose.

  • Clinical Trial
  • Pain Relief
  • United States
  • Company
  • Capnia, Inc.
  • Jun 17, 2016: Zosano Pharma Enrolls First Subject in Pivotal Clinical Trial for ZP-Triptan Patch Program for Treatment of Migraine

Fast absorption is believed to correlate with rapid pain relief for migraine patients.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation
  • KETOPROFEN - DRUG PROFILE
  • KETOPROFEN - DRUG PROFILE

Additional endpoints showed that levadex provided rapid and sustained pain relief for up to ## hours after dosing.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc
  • Product Development Milestones

Cytogel Pharma provides pain relief and polymer systems used for making biological drugs.

  • Pain Relief
  • United States
  • Company
  • Product Initiative
  • Pfizer Inc.
  • NOV 09, 2016: COLUCID PHARMACEUTICALS ANNOUNCES 2016 THIRD QUARTER RESULTS AND CORPORATE HIGHLIGHTS

Both the ## mg and ## mg doses of lasmiditan were also more efficacious than placebo on headache pain relief at the two-hour time point (p ##. ##), as a rescue medication on headache pain freedom at the two-hour time point (p ##. ## and p ##. ##), in reducing migraine related disability at t

  • Pain Relief
  • Pharmaceutical
  • United States
  • Corporate Finance
  • CoLucid Pharmaceuticals, Inc.

The primary efficacy endpoint of the trial is pain relief as reported on a visual analog scale (VAS) in a subject diary, assessed through ## hours from initial dose.

  • Clinical Trial
  • Pain Relief
  • United States
  • Company
  • Capnia, Inc.

Fast absorption is believed to correlate with rapid pain relief for migraine patients.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Company
  • Zosano Pharma Corporation

The secondary outcome measures were modified brief pain inventory short form (mbpi-sf) intensity, To evaluate pain relief using the pain relief item of the mbpi-sf, To evaluate the pain-related quality of life using the pain interference subscale of the mbpi-sf, Western ontario and

  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Mallinckrodt plc
  • Other Developmental Activities
  • dihydroergotamine mesylate

Additional endpoints showed that levadex provided rapid and sustained pain relief for up to ## hours after dosing.

  • Pain Relief
  • Therapy
  • United States
  • M&A
  • Allergan plc
  • FEATURED NEWS & PRESS RELEASES

Better tissue penetration should reduce inflammatory symptoms, which are key to preventing post-surgical side effects, in addition to providing longer lasting pain relief to patients. "

  • Eye Disease
  • Pain Relief
  • United States
  • Product Initiative
  • InSite Vision Incorporated
  • dihydroergotamine mesylate

Additional endpoints showed that levadex provided rapid and sustained pain relief for up to ## hours after dosing.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc